Healthcare Sector — activité des initiés

Suivez les achats et ventes d’initiés sur les actions de Healthcare. Découvrez quels dirigeants achètent, l’activité nette des initiés et le pourcentage du flottant échangé parmi 3,238 sociétés.
Les informations fournies dans ce classement sont à titre informatif uniquement et ne constituent pas un conseil financier. Nous ne recommandons aucun investissement spécifique basé sur ces critères.
Entreprises
Données
Abonnez-vous pour accéder à l'ensemble des données
Entreprise Secteur d'activité Cap. boursière (USDm) # acheteurs nets Valeur nette ($) % du flottant acheté % d'actions détenues par les initiés
Pharmaceuticals & Medical Research Mid (6.4bn) -1–5 -$100K–$1M -0–15% 0–15%
US Liquidia Corp (LQDA)
Pharmaceuticals & Medical Research Mid (6.2bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (6.2bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (6.1bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (6.1bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (6.1bn) 0 Aucune activité — 0–15%
DK H Lundbeck A/S (HLUN-A)
Pharmaceuticals & Medical Research Mid (6.1bn) 0 Aucune activité — 0–15%
US R1 RCM Inc (RCM)
Healthcare Services Mid (6.0bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (6.0bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mid (6.0bn) -1–5 -$1M–$10M -0–15% 50%+
Pharmaceuticals & Medical Research Mid (6.0bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mid (5.9bn) -1–5 -$100K–$1M -0–15% 50%+
US Teleflex Inc (TFX)
Healthcare Services Mid (5.8bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (5.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mid (5.7bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (5.7bn) -1–5 -$10M–$100M -0–15% 0–15%
US Erasca Inc (ERAS)
Pharmaceuticals & Medical Research Mid (5.7bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (5.6bn) 0 Aucune activité — 0–15%
SE Sectra AB (SECT-B)
Healthcare Services Mid (5.6bn) -1–5 -$100K–$1M -0–15% 15–50%
Pharmaceuticals & Medical Research Mid (5.6bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Mid (5.6bn) -1–5 -$100M+ -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (5.5bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (5.4bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mid (5.4bn) -1–5 -$10M–$100M -0–15% 0–15%
US LHC Group Inc (LHCG)
Healthcare Services Mid (5.3bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (5.3bn) 0 Aucune activité — 0–15%
US Celcuity Inc (CELC)
Pharmaceuticals & Medical Research Mid (5.2bn) -1–5 -$100M+ -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (5.2bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Mid (5.2bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (5.1bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (5.1bn) 1–5 $1M–$10M 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (5.0bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (5.0bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Mid (5.0bn) 0 Aucune activité — 50%+
Healthcare Services Mid (5.0bn) -6–10 -$100M+ -0–15% 0–15%
Healthcare Services Mid (5.0bn) 0 Aucune activité — 50%+
Healthcare Services Mid (4.9bn) 0 Aucune activité — 0–15%
IN Ajanta Pharma Ltd (AJANTPHARM)
Pharmaceuticals & Medical Research Mid (4.8bn) -1–5 -$100K–$1M -0–15% 50%+
Pharmaceuticals & Medical Research Mid (4.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (4.7bn) 0 Aucune activité — 15–50%
Healthcare Services Mid (4.7bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (4.7bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (4.7bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (4.6bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (4.6bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (4.6bn) 1–5 < $100K 0–15% 50%+
Pharmaceuticals & Medical Research Mid (4.6bn) 1–5 $100K–$1M 0–15% 15–50%
Pharmaceuticals & Medical Research Mid (4.6bn) -1–5 -$100M+ -0–15% 0–15%
Healthcare Services Mid (4.5bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (4.5bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (4.5bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (4.5bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (4.5bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (4.5bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (4.4bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (4.4bn) 0 Aucune activité — 50%+
Healthcare Services Mid (4.4bn) -1–5 -$1M–$10M -0–15% 0–15%
US LivaNova PLC (LIVN)
Healthcare Services Mid (4.4bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (4.4bn) 0 Aucune activité — 0–15%
IN Biocon Ltd (BIOCON)
Pharmaceuticals & Medical Research Mid (4.3bn) 0 Aucune activité — 50%+
Healthcare Services Mid (4.3bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (4.3bn) -1–5 -$10M–$100M -0–15% 0–15%
US Heartflow Inc (HTFL)
Healthcare Services Mid (4.3bn) 0 Aucune activité — 0–15%
GB Indivior PLC (INDV)
Pharmaceuticals & Medical Research Mid (4.2bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (4.2bn) -1–5 -$100M+ -0–15% 0–15%
US RadNet Inc (RDNT)
Healthcare Services Mid (4.2bn) 0 Aucune activité — 0–15%
US Alkermes Inc (ALKS)
Pharmaceuticals & Medical Research Mid (4.1bn) 0 Aucune activité — 0–15%
US TESARO Inc (TSRO)
Pharmaceuticals & Medical Research Mid (4.1bn) 0 Aucune activité — —
US Metsera Inc (MTSR)
Pharmaceuticals & Medical Research Mid (4.1bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (4.1bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (4.1bn) -1–5 -< $100K -0–15% 15–50%
Healthcare Services Mid (4.1bn) 0 Aucune activité — 50%+
Healthcare Services Mid (4.0bn) -6–10 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (3.9bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (3.9bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (3.9bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (3.9bn) 0 Aucune activité — 0–15%
SE Camurus AB (CAMX)
Pharmaceuticals & Medical Research Mid (3.8bn) -1–5 -$100K–$1M -0–15% 15–50%
Pharmaceuticals & Medical Research Mid (3.8bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (3.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (3.8bn) 1–5 $1M–$10M 0–15% 15–50%
Pharmaceuticals & Medical Research Mid (3.8bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (3.8bn) 1–5 $100K–$1M 0–15% 50%+
US Perrigo Co (PRGO)
Pharmaceuticals & Medical Research Mid (3.8bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (3.7bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (3.7bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (3.7bn) 0 Aucune activité — 15–50%
SE Medicover AB (MCOV-B)
Healthcare Services Mid (3.7bn) 0 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (3.7bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (3.6bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (3.6bn) 0 Aucune activité — 0–15%
US Organon & Co (OGN)
Pharmaceuticals & Medical Research Mid (3.6bn) -1–5 -$100K–$1M -0–15% 0–15%
US Grail Inc (GRAL)
Pharmaceuticals & Medical Research Mid (3.6bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mid (3.6bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Mid (3.6bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mid (3.6bn) -1–5 -$1M–$10M -0–15% 15–50%
US CorVel Corp (CRVL)
Healthcare Services Mid (3.6bn) -1–5 -$10M–$100M -0–15% 15–50%
Pharmaceuticals & Medical Research Mid (3.5bn) -1–5 -< $100K -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (3.5bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (3.5bn) 0 Aucune activité — 50%+